论文部分内容阅读
目的研究临床降糖口服药物的使用规律。方法选择2016年1-12月医院治疗的高血糖患者650例,分析其相关病历中的口服降糖药物领用量,从药理学角度分析医院治疗方案的有效性。结果二甲双胍是目前用量最大的口服降糖药物,占总用药量的40.11%,二甲双胍、磺脲类、α糖苷酶抑制剂三个药物用量之和达到总药物用量的83.48%,为主流口服降糖药物。结论当前的医学条件下,使用二甲双胍类药物、磺脲类药物、α糖苷酶抑制剂药物进行糖尿病血糖控制是有效的。
Objective To study the clinical use of oral hypoglycemic agents. Methods Six hundred and sixty-six patients with hyperglycemia admitted to hospital from January to December in 2016 were selected. The amount of oral hypoglycemic agents in their medical records was analyzed, and the effectiveness of hospital treatment was analyzed from the perspective of pharmacology. The results of metformin is currently the largest amount of oral hypoglycemic drugs, accounting for 40.11% of the total dose of metformin, sulfonylureas, α-glucosidase inhibitors and the total amount of the three drugs reached 83.48% of total drug consumption, the mainstream oral hypoglycemic drug. Conclusions Under the current medical conditions, the use of metformin, sulfonylureas and α-glucosidase inhibitors is effective in controlling diabetic blood glucose.